EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALIGNANT OVARY, BENIGN OVARIAN-TUMORS AND NORMAL OVARY - A COMPARISON

  • Authors:
    • OJ OWENS
    • RE LEAKE
  • View Affiliations

  • Published online on: February 1, 1993     https://doi.org/10.3892/ijo.2.2.321
  • Pages: 321-324
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epidermal growth factor receptor (EGFR) was assayed and compared in malignant ovaries, benign ovarian tumours and normal ovaries. The EGFR was present in 39.7% of malignant ovaries, 13.3% of benign ovarian tumours and in 15.4% of normal ovaries. In the malignant group 36 samples had a low affinity component, 27 had a high affinity component and 16 had both high and low affinity components. The benign ovarian group had 1 high affinity and 3 low affinity components while the normal ovaries had 3 high affinity and 5 low affinity components. The sensitivity of the EGFR assay was 39.7% and the specificity 85.4%.

Related Articles

Journal Cover

February 1993
Volume 2 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
OWENS O and LEAKE R: EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALIGNANT OVARY, BENIGN OVARIAN-TUMORS AND NORMAL OVARY - A COMPARISON. Int J Oncol 2: 321-324, 1993.
APA
OWENS, O., & LEAKE, R. (1993). EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALIGNANT OVARY, BENIGN OVARIAN-TUMORS AND NORMAL OVARY - A COMPARISON. International Journal of Oncology, 2, 321-324. https://doi.org/10.3892/ijo.2.2.321
MLA
OWENS, O., LEAKE, R."EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALIGNANT OVARY, BENIGN OVARIAN-TUMORS AND NORMAL OVARY - A COMPARISON". International Journal of Oncology 2.2 (1993): 321-324.
Chicago
OWENS, O., LEAKE, R."EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN MALIGNANT OVARY, BENIGN OVARIAN-TUMORS AND NORMAL OVARY - A COMPARISON". International Journal of Oncology 2, no. 2 (1993): 321-324. https://doi.org/10.3892/ijo.2.2.321